Empagliflozin Versus Vildagliptin in CAD Patients With T2DM

Clinical trial NCT06313008 · COMPLETED

Trial details

NCT number: NCT06313008
Sponsor: Damanhour University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronary Artery Disease Type 2 Diabetes

Start date: 2023-08-10
Primary completion: 2024-09-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.